Waiver Of Indemnity Claims By Vaccine Manufacturers

The recent buzz in the news on vaccine supply ran thus: “Pfizer wants vaccine disputes only in US Courts apart from indemnity waiver in case of adverse effects”; “Vaccine manufacturers Moderna and Pfizer are ready to supply their COVID-19 vaccines to India provided the Government of India gives them indemnity against any liabilities from the usage of their vaccines.” This trend has spurred us to analyze the scope of indemnity waiver in product liability cases.

It is a given that no degree of care and caution at the pre-clinical and clinical testing stages can guarantee absolute safety when a product is marketed and prescribed in large populations where prevailing conditions are different from those of the clinical trials. Thus, a strong pharmacovigilance system is required to ensure the continuous monitoring and evaluation of the new safety data generated under real-world conditions.

Please click here to read the full article by Sanjay Kumar published in BW Legal World.